Sofinnova Capital VII FCPR 4
4 · Shockwave Medical, Inc. · Filed Aug 21, 2020
Insider Transaction Report
Form 4
Sofinnova Capital VII FCPR
10% Owner
Transactions
- Sale
Common Stock
2020-08-20$60.01/sh−33,822$2,029,658→ 1,960,384 total - Sale
Common Stock
2020-08-21$60.02/sh−21,536$1,292,591→ 1,938,848 total
Footnotes (3)
- [F1]Shares held by the reporting person are also reported on Form 4 by Antoine Papiernik, one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of the reporting person. Mr. Papiernik disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
- [F2]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $60.00 to $60.24. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $60.00 to $60.18. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.